Menopause Clinical Trials

We are looking for postmenopausal women who experience vaginal dryness or pain to participate in a research study that compares an investigational vaginal cream to an already marketed vaginal cream.

Attention hot flash sufferers! Mount Vernon Clinical Research is enrolling women experiencing hot flashes in a clinical research study.

Diablo Clinical Research is conducting a clinical research study to evaluate an investigational medication in postmenopausal women to see its effect on cholesterol. You may qualify for the study if you are: A woman Post menopausal In good general health Not using hormone therapy Qualified participants may receive at no ...

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Vaginal atrophy, also called (Vaginal Dryness/Irritation/Painful Intercourse), is thinning, drying and inflammation of the vaginal walls due to your body having less estrogen. Vaginal atrophy occurs most often after menopause. For many women, vaginal atrophy makes intercourse painful — and if intercourse hurts, your interest in sex will naturally decrease. ...

Twelve week study of an estrogen vaginal suppository, six visits, to assess its impact on vaginal dryness and pain in menopausal women.

A Study to Evaluate the Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) due to Menopause.

Are you a woman experiencing menopause? If so you may be experiencing one or more of the unpleasant symptoms that come with this experience. These are the symptoms of menopause that pharmaceutical companies are trying to find treatments for. Horizons Clinical Research Center, LLC often conducts studies for these new ...

This study is to compare the efficacy of study drug, Enobosarm, administered once daily to that of placebo by evaluating the number of subject reported stress incontinence episodes per day.

To evaluate safety and efficacy of CE/BZA in real practice in Korea